EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond

Harika Dasari, Anna Smyrnova, Jing Leng, Francine M Ducharme iD

PLOS ONE · 29.05.2024 · 19 (5) · e0304155

DOI: 10.1371/journal.pone.0304155 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 29.05.2024. Verfasst von Harika Dasari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Knowledge Transfer Unit on Childhood Asthma, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Blood Specimen Collection. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Home blood self-collection devices can enable remote monitoring, but their implementation requires validation. Our objectives were to explore (i) the impact of sampling sites and topical analgesia on capillary blood volume and pain perception and (ii) the safety, acceptability, and failure of capillary self-collection among adults and children using the Tasso-SST device.

Methods

We conducted a two-phase study. The investigational phase consisted of two on-site cross-sectional studies in healthy adult participants (≥ 12 years) and children (1–17 years) with their accompanying parent. Adults received 4 capillary samplings, where puncture sites and topical analgesia were randomized in a factorial design, and a venipuncture; children (and one parent) had one capillary sampling. The two co-primary outcomes were blood volume and pain. The implementation phase was conducted in two multicentre trials in participants choosing remote visits; blood volume, collection failure, adverse events, and satisfaction were documented.

Results

In the investigational phase , 90 participants and 9 children with 7 parents were enrolled; 15 adults and 2 preschoolers participated in the implementation phase . In the adult investigational study, the device collected a median (25%, 75%) of 450 (250, 550) μl of blood with no significant difference between the puncture site, topical analgesia, and its interaction. Using topical analgesia reduced pain perception by 0.61 (95% CI: 0.97, 0.24; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Specimen CollectionHumansChildAdultMaleFemaleAdolescentChild, PreschoolMiddle AgedCross-Sectional StudiesCOVID-19InfantPhlebotomyFeasibility StudiesYoung AdultPandemicsCapillariesBlood Volume

Autor:innen und Institutionen

  • Clinical Research and Knowledge Transfer Unit on Childhood Asthma, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Department of Pediatrics, University of Montréal, Quebec, Canada.
  • Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Québec, Canada.

ORCID-Profile: Francine M Ducharme

Förderung

  • Canadian Institute of Health Research

Zitieren

APA

Dasari, H., Smyrnova, A., Leng, J., & Ducharme, F. M. (2024). Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond. PLOS ONE, 19(5), e0304155. https://doi.org/10.1371/journal.pone.0304155

Vancouver

Dasari H, Smyrnova A, Leng J, Ducharme FM. Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond. PLOS ONE. 2024;19(5):e0304155. doi:10.1371/journal.pone.0304155

BibTeX
@article{Dasari2024,
  author = {Dasari, Harika and Smyrnova, Anna and Leng, Jing and Ducharme, Francine M},
  title = {Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0304155},
  doi = {10.1371/journal.pone.0304155}
}
Kostenlos starten →